MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Evaluating Adaptive Devices to Assist Eating in Essential Tremor Patients: A Comparative Analysis

    K. Adabi, W. Ondo (Houston, USA)

    Objective: To evaluate the effectiveness of six adaptive devices to mitigate tremor impact while eating in patients with essential tremor (ET), compared to a standard…
  • 2024 International Congress

    Is the sebum RNA transcriptome analysis technique capable of non-invasively diagnosing Parkinson’s disease?

    T. Iseki, Y. Ueda, T. Kuwano, T. Inoue, S. Saiki, N. Hattori (Bunkyo-ku, Japan)

    Objective: Our goal was to explore the potential of skin-surface lipid RNA transcriptome analysis as a diagnostic tool for Parkinson's disease. Background: Seborrheic dermatitis is…
  • 2024 International Congress

    Model-Based Gait Outcomes to Track Parkinson’s Disease Progression ?

    CE. Mvomo, J. Bedime, S. Perfetto, I. Sierra, H. Lajeunesse, A. Potvin-Desrochers, CA. Easthope, C. Paquette (Montreal, Canada)

    Objective: To determine whether outcomes extracted from a gait model can serve as markers of symptoms and neurodegeneration progression in Parkinson’s disease (PD). Background: Longitudinal…
  • 2024 International Congress

    Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson’s Disease

    H. Mao, Y. Kuang, P. Xu (guangzhou, China)

    Objective: To develop a technology capable of ultra-sensitive, in situ amplification of abnormal conformations of αSyn within biological samples, potentially enhancing diagnostic accuracy and shedding…
  • 2024 International Congress

    Can Technology Improve Service Delivery and Patient Outcomes in a Parkinson’s Speech and Language Therapy Clinic?

    C. Meskill, C. Bartliff, J. O'Loughlin (Cork, Ireland)

    Objective: -       Determine if Telea, an online care platform, can aid in efficiently addressing caseload needs and quantify clinical time saved through…
  • 2024 International Congress

    Tension Pneumocephalus as an acute complication of STN-DBS surgery

    E. Rosa Fernandes, L. Bassani Devens, G. Dick Bonato, J. Junqueira Bizzi, L. Frighetto, P. Petry Oppitz, S. Trentin, B. Fraiman Oliveira, Y. Felloni Borges (Porto Alegre, Brazil)

    Objective: To describe a rare complication of Deep Brain Stimulation (DBS). Background: DBS is a surgical treatment for Parkinson´s Disease (PD). Among the possible surgical…
  • 2024 International Congress

    Deep Brain Stimulation Complications in Parkinson’s Disease Patients: A 15-year Single-Centre Review

    J. Cheong, S. Welch, M. Nasir, R. Matar, H. Low, A. Misbahuddin (London, United Kingdom)

    Objective: This study aims to identify the complications of subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with advanced Parkinson’s disease (PD) to direct…
  • 2024 International Congress

    Evaluation of Glymphatic System Function in Parkinson’s disease patients using Diffusion MRI

    M. Seki, R. Ueda, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, T. Tezuka, Y. Nihei, J. Nakahara (Tokyo, Japan)

    Objective: To investigate the activity and clinical significance of glymphatic system in Parkinson's disease (PD) patients using diffusion MRI. Background: Although much research on proteinopathies…
  • 2024 International Congress

    IGF2 Induce Neuroprotection in PD Preclinical Models by Modulation of Immune Response.

    FG. Grünenwald, MC. Cisternas, DS. Sepulveda, TH. Huerta, CJ. Jerez, RP. Pacheco, RLV. Vidal (Santiago, Chile)

    Objective: We propose to determine a therapeutic strategy based on adoptive transfer of macrophages reprogrammed for recombinant IGF2 (rIGF2) treatment in PD preclinical model. Background:…
  • 2024 International Congress

    Multicentric Randomized Control Trial of Buspirone in Levodopa-Induced Dyskinesias

    H. Salhi, D. Maltête, S. Thobois, G. Fenelon, F. Ory, L. Defevre, G. Mangone, G. Defer, AR. Marques, S. Frismand, S. Drapier, JP. Azulay, C. Geny, G. Dupont, A. Doe-de-Maindreville, C. Barberot, D. Devos, JC. Corvol, O. Rascol, E. Audureau, P. Remy (Creteil, France)

    Objective: To investigate the efficacy of buspirone on levodopa induced dyskinesias (LID) in Parkinson disease (PD) patients Background: LID could be partially mediated by the…
  • « Previous Page
  • 1
  • …
  • 449
  • 450
  • 451
  • 452
  • 453
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley